Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036515189> ?p ?o ?g. }
- W2036515189 endingPage "e223" @default.
- W2036515189 startingPage "e217" @default.
- W2036515189 abstract "A residual platelet reactivity (RPR) on antiplatelet therapy in patients with ischemic heart disease (IHD) has been reported to be associated with adverse clinical events by some Authors. However, scarce data are present on the clinical parameters associated with this phenomenon. No study, at our knowledge, was designed with the specific aim to examine the relationship between clinical characteristics and RPR. We sought to evaluate the clinical and laboratory characteristics associated with RPR in patients with IHD undergoing coronary revascularization on dual (aspirin plus clopidogrel) antiplatelet therapy. We included in the study 868 patients undergoing a coronary angiography: 386 with acute coronary syndromes undergoing a primary coronary revascularization and 482 IHD patients scheduled to undergo an elective coronary angiography. We measured platelet function by both platelet aggregation with two agonists [0.5 mg/mL arachidonic acid (AA); 2 and 10 μM adenosine 5′-diphosphate (ADP)] and a point-of-care assay (PFA-100) on venous blood samples collected within 24 h from the end of the procedure. In patients with acute coronary syndromes and elective PCI diabetes is independently associated with RPR [group A: OR = 2.9 (1.5–5.7) by 10 μM ADP, OR = 5.3 (1.1–27.8) by PFA-100; group B: OR = 4.0 (1.6–10.0) by 10 μM ADP]; reduced left ventricular systolic function [OR = 3.7 (2.2–6.5) by AA-PA, OR = 2.7 (1.6–4.6) by PFA-100], chronic use of aspirin [OR = 0.2 (0.1–0.4) by AA-PA, OR = 0.3 (0.2–0.5) by PFA-100] and loading dose of clopidogrel [OR = 0.2 (0.06–0.5) by 10 μM ADP] were independent variables significantly associated with RPR in patients undergoing elective PCI. In addition, inflammatory status was found to be significantly associated with RPR in both groups of patients. These results provide indications for the selection of patients for whom the evaluation of platelet reactivity could be useful." @default.
- W2036515189 created "2016-06-24" @default.
- W2036515189 creator A5006597199 @default.
- W2036515189 creator A5032915592 @default.
- W2036515189 creator A5034187749 @default.
- W2036515189 creator A5036684831 @default.
- W2036515189 creator A5044940459 @default.
- W2036515189 creator A5060169707 @default.
- W2036515189 creator A5070057174 @default.
- W2036515189 creator A5076179755 @default.
- W2036515189 date "2007-11-01" @default.
- W2036515189 modified "2023-09-25" @default.
- W2036515189 title "Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy" @default.
- W2036515189 cites W141287021 @default.
- W2036515189 cites W1460114693 @default.
- W2036515189 cites W1726466368 @default.
- W2036515189 cites W1989615944 @default.
- W2036515189 cites W1998097763 @default.
- W2036515189 cites W2007675502 @default.
- W2036515189 cites W2011854883 @default.
- W2036515189 cites W2023429077 @default.
- W2036515189 cites W2024352468 @default.
- W2036515189 cites W2048708470 @default.
- W2036515189 cites W2049449845 @default.
- W2036515189 cites W2052106438 @default.
- W2036515189 cites W2058874291 @default.
- W2036515189 cites W2059064084 @default.
- W2036515189 cites W2060063218 @default.
- W2036515189 cites W2061975208 @default.
- W2036515189 cites W2062858371 @default.
- W2036515189 cites W2074959127 @default.
- W2036515189 cites W2078474866 @default.
- W2036515189 cites W2089858634 @default.
- W2036515189 cites W2097514615 @default.
- W2036515189 cites W2104595603 @default.
- W2036515189 cites W2120865130 @default.
- W2036515189 cites W2128630796 @default.
- W2036515189 cites W2129001881 @default.
- W2036515189 cites W2129774942 @default.
- W2036515189 cites W2130350603 @default.
- W2036515189 cites W2135194780 @default.
- W2036515189 cites W2146165961 @default.
- W2036515189 cites W2147195562 @default.
- W2036515189 cites W2147294426 @default.
- W2036515189 cites W2156121263 @default.
- W2036515189 cites W2161043271 @default.
- W2036515189 cites W2165160171 @default.
- W2036515189 cites W2324841714 @default.
- W2036515189 cites W2330471697 @default.
- W2036515189 cites W23524587 @default.
- W2036515189 cites W4230870013 @default.
- W2036515189 cites W4234393699 @default.
- W2036515189 doi "https://doi.org/10.1016/j.atherosclerosis.2007.04.048" @default.
- W2036515189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17555759" @default.
- W2036515189 hasPublicationYear "2007" @default.
- W2036515189 type Work @default.
- W2036515189 sameAs 2036515189 @default.
- W2036515189 citedByCount "44" @default.
- W2036515189 countsByYear W20365151892012 @default.
- W2036515189 countsByYear W20365151892013 @default.
- W2036515189 countsByYear W20365151892014 @default.
- W2036515189 countsByYear W20365151892015 @default.
- W2036515189 countsByYear W20365151892016 @default.
- W2036515189 countsByYear W20365151892017 @default.
- W2036515189 countsByYear W20365151892018 @default.
- W2036515189 crossrefType "journal-article" @default.
- W2036515189 hasAuthorship W2036515189A5006597199 @default.
- W2036515189 hasAuthorship W2036515189A5032915592 @default.
- W2036515189 hasAuthorship W2036515189A5034187749 @default.
- W2036515189 hasAuthorship W2036515189A5036684831 @default.
- W2036515189 hasAuthorship W2036515189A5044940459 @default.
- W2036515189 hasAuthorship W2036515189A5060169707 @default.
- W2036515189 hasAuthorship W2036515189A5070057174 @default.
- W2036515189 hasAuthorship W2036515189A5076179755 @default.
- W2036515189 hasBestOaLocation W20365151892 @default.
- W2036515189 hasConcept C126322002 @default.
- W2036515189 hasConcept C134018914 @default.
- W2036515189 hasConcept C164705383 @default.
- W2036515189 hasConcept C2777628954 @default.
- W2036515189 hasConcept C2777698277 @default.
- W2036515189 hasConcept C2777849778 @default.
- W2036515189 hasConcept C2779464278 @default.
- W2036515189 hasConcept C2780400711 @default.
- W2036515189 hasConcept C45393284 @default.
- W2036515189 hasConcept C49059817 @default.
- W2036515189 hasConcept C500558357 @default.
- W2036515189 hasConcept C555293320 @default.
- W2036515189 hasConcept C71924100 @default.
- W2036515189 hasConcept C89560881 @default.
- W2036515189 hasConceptScore W2036515189C126322002 @default.
- W2036515189 hasConceptScore W2036515189C134018914 @default.
- W2036515189 hasConceptScore W2036515189C164705383 @default.
- W2036515189 hasConceptScore W2036515189C2777628954 @default.
- W2036515189 hasConceptScore W2036515189C2777698277 @default.
- W2036515189 hasConceptScore W2036515189C2777849778 @default.
- W2036515189 hasConceptScore W2036515189C2779464278 @default.
- W2036515189 hasConceptScore W2036515189C2780400711 @default.
- W2036515189 hasConceptScore W2036515189C45393284 @default.